Yingjie He

Key Laboratory Of Post‑Neuroinjury Neuro‑Repair And Regeneration In Central Nervous System
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Bufalin enhanced temozolomide efficacy by promoting EGFR protein degradation in glioblastoma.

Bufalin enhanced temozolomide efficacy by promoting EGFR protein degradation in glioblastoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 11, 2025

Efficient voltammetric analysis for total inorganic arsenic detection in rice with enhanced sensitivity and selectivity.

Efficient voltammetric analysis for total inorganic arsenic detection in rice with enhanced sensitivity and selectivity.

Journal: Food chemistry: X

Published: October 12, 2024

USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC.

USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC.

Journal: Cell death & disease

Published: September 01, 2024

A novel gene signature based on endoplasmic reticulum stress for predicting prognosis in hepatocellular carcinoma.

A novel gene signature based on endoplasmic reticulum stress for predicting prognosis in hepatocellular carcinoma.

Journal: Translational cancer research

Published: January 29, 2024

Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review).

Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review).

Journal: International journal of oncology

Published: May 05, 2023

Novel insight into the functions of N6‑methyladenosine modified lncRNAs in cancers (Review).

Novel insight into the functions of N6‑methyladenosine modified lncRNAs in cancers (Review).

Journal: International journal of oncology

Published: July 08, 2022

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway.

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway.

Journal: Cell death & disease

Published: June 29, 2022

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.

Journal: Frontiers in immunology

Published: May 15, 2022

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.

Journal: Frontiers in immunology

Published: January 06, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026